These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28722190)
1. Estimating population effects of vaccination using large, routinely collected data. Halloran ME; Hudgens MG Stat Med; 2018 Jan; 37(2):294-301. PubMed ID: 28722190 [TBL] [Abstract][Full Text] [Related]
2. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach. Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820 [TBL] [Abstract][Full Text] [Related]
3. Report of the second European expert meeting on rotavirus vaccination. Giaquinto C; Jackson AE; Vesikari T Vaccine; 2012 Mar; 30(13):2237-44. PubMed ID: 22178724 [No Abstract] [Full Text] [Related]
4. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Ryan J; Zoellner Y; Gradl B; Palache B; Medema J Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909 [TBL] [Abstract][Full Text] [Related]
5. Learning to Trust Flu Shots: Quasi-Experimental Evidence from the 2009 Swine Flu Pandemic. Maurer J; Harris KM Health Econ; 2016 Sep; 25(9):1148-62. PubMed ID: 27381724 [TBL] [Abstract][Full Text] [Related]
6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010. Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223 [TBL] [Abstract][Full Text] [Related]
9. Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009. Vesikari T; Sutherland D; Jackson AE Vaccine; 2009 Dec; 27(52):7222-7. PubMed ID: 19822233 [No Abstract] [Full Text] [Related]
10. A mathematical model of the indirect effects of rotavirus vaccination. Van Effelterre T; Soriano-Gabarró M; Debrus S; Claire Newbern E; Gray J Epidemiol Infect; 2010 Jun; 138(6):884-97. PubMed ID: 20028612 [TBL] [Abstract][Full Text] [Related]
11. High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity. Matsuoka T; Sato T; Akita T; Yanagida J; Ohge H; Kuwabara M; Tanaka J Int J Environ Res Public Health; 2016 Oct; 13(10):. PubMed ID: 27763532 [TBL] [Abstract][Full Text] [Related]
12. Influenza vaccination in older people with diabetes and their household contacts. Yang L; Nan H; Liang J; Chan YH; Chan L; Sum RW; Kwan YM; Zhou F; Meng H; Suen LK Vaccine; 2017 Feb; 35(6):889-896. PubMed ID: 28094076 [TBL] [Abstract][Full Text] [Related]
13. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty. Yi J; Anderson EJ Expert Rev Vaccines; 2013 Jun; 12(6):585-7. PubMed ID: 23750788 [No Abstract] [Full Text] [Related]
14. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539 [TBL] [Abstract][Full Text] [Related]
15. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880 [TBL] [Abstract][Full Text] [Related]